Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

0QNV

Addex Therapeutics (0QNV)

Addex Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0QNV
DateTimeSourceHeadlineSymbolCompany
29/04/202415:00UK RegulatoryAddex Provides Update on ADX71149 Phase 2 Epilepsy StudyLSE:0QNVAddex Therapeutics Ltd
19/04/202415:00UK RegulatoryAddex to Present at the Swiss Biotech Day 2024LSE:0QNVAddex Therapeutics Ltd
18/04/202415:00UK RegulatoryAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
11/04/202415:00UK RegulatoryAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024LSE:0QNVAddex Therapeutics Ltd
03/04/202416:00UK RegulatoryAddex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersLSE:0QNVAddex Therapeutics Ltd
14/03/202417:00UK RegulatoryAddex to Present at the Bio-Europe Spring 2024 ConferenceLSE:0QNVAddex Therapeutics Ltd
31/01/202417:00UK RegulatoryAddex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.LSE:0QNVAddex Therapeutics Ltd
 Showing the most relevant articles for your search:LSE:0QNV